Ademi LLP is investigating Vivint (NYSE: VVNT) for possible breaches of fiduciary duty and other violations of law in its transaction with NRG.
Ademi LLP alleges Vivint’s financial outlook and prospects are excellent and yet Vivint shareholders are expected to receive only $12 per share or $2.8 billion in an all-cash transaction. The transaction agreement unreasonably limits competing bids for Vivint by imposing a significant penalty if Vivint accepts a superior bid. Vivint insiders will receive substantial benefits as part of change of control arrangements.
We are investigating the conduct of Vivint’s board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Vivint.